These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15448578)

  • 1. Antispasticity medications: uses and limitations of enteral therapy.
    Zafonte R; Lombard L; Elovic E
    Am J Phys Med Rehabil; 2004 Oct; 83(10 Suppl):S50-8. PubMed ID: 15448578
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacotherapy of spasticity: oral medications and intrathecal baclofen.
    Krach LE
    J Child Neurol; 2001 Jan; 16(1):31-6. PubMed ID: 11225954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of spasticity, pain, and paroxysmal phenomena in multiple sclerosis.
    Schapiro RT
    Curr Neurol Neurosci Rep; 2001 May; 1(3):299-302. PubMed ID: 11898533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABA agonists and gabapentin for spastic hypertonia.
    Francisco GE; Kothari S; Huls C
    Phys Med Rehabil Clin N Am; 2001 Nov; 12(4):875-88, viii. PubMed ID: 11723868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.
    Otero-Romero S; Sastre-Garriga J; Comi G; Hartung HP; Soelberg Sørensen P; Thompson AJ; Vermersch P; Gold R; Montalban X
    Mult Scler; 2016 Oct; 22(11):1386-1396. PubMed ID: 27207462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spasticity: revisiting the role and the individual value of several pharmacological treatments.
    Lapeyre E; Kuks JB; Meijler WJ
    NeuroRehabilitation; 2010; 27(2):193-200. PubMed ID: 20871149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gabapentin for intractable hiccup.
    Hernández JL; Pajarón M; García-Regata O; Jiménez V; González-Macías J; Ramos-Estébanez C
    Am J Med; 2004 Aug; 117(4):279-81. PubMed ID: 15308440
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacological treatment of nystagmus].
    Pieh-Beisse C; Lagrèze WA
    Ophthalmologe; 2011 Feb; 108(2):178-82. PubMed ID: 21253746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The pharmacology of spasticity].
    Morel N
    J Belge Med Phys Rehabil; 1980; 3(2):105-12. PubMed ID: 9139023
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute care management of post-TBI spasticity.
    Zafonte R; Elovic EP; Lombard L
    J Head Trauma Rehabil; 2004; 19(2):89-100. PubMed ID: 15247820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gabapentin for the treatment of spasticity in patients with amyotrophic lateral sclerosis.
    de Carvalho M
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Mar; 2(1):47-8. PubMed ID: 11465933
    [No Abstract]   [Full Text] [Related]  

  • 12. The pharmacological management of spasticity.
    Saulino M; Jacobs BW
    J Neurosci Nurs; 2006 Dec; 38(6):456-9. PubMed ID: 17233517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological treatment of spasticity in multiple sclerosis].
    Heinzlef O; Monteil-Roch I
    Rev Neurol (Paris); 2012 Apr; 168 Suppl 3():S62-8. PubMed ID: 22721367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medical treatment of spasticity].
    Rode G; Maupas E; Luaute J; Courtois-Jacquin S; Boisson D
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):247-55. PubMed ID: 12746699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of spasticity.
    Rösche J
    Spinal Cord; 2002 Jun; 40(6):261-2. PubMed ID: 12037705
    [No Abstract]   [Full Text] [Related]  

  • 16. [When and how to prescribe muscle relaxants in spasticity ?].
    Delwaide PJ; Burton L
    Rev Med Liege; 1981 Apr; 36(7):268-71. PubMed ID: 7291810
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyproheptadine for intrathecal baclofen withdrawal.
    Meythaler JM; Roper JF; Brunner RC
    Arch Phys Med Rehabil; 2003 May; 84(5):638-42. PubMed ID: 12736874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha adrenergic and serotonergic agents in the treatment of spastic hypertonia.
    Nance PW
    Phys Med Rehabil Clin N Am; 2001 Nov; 12(4):889-905. PubMed ID: 11723869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of cerebral palsy: subjectivity and a conundrum.
    Bodensteiner JB
    J Child Neurol; 1996 Mar; 11(2):75-76. PubMed ID: 8881980
    [No Abstract]   [Full Text] [Related]  

  • 20. [Orally administered drugs in the treatment of spasticity].
    Campistol J
    Rev Neurol; 2003 Jul 1-15; 37(1):70-4. PubMed ID: 12861514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.